An Wouters

10PUBLICATIONS
29CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyRadiation therapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 18, 2026
DRP1 depletion protects NK cells from hypoxia-induced dysfunction.

Tias Verhezen, Astrid Van Den Eynde, Peter Verstraelen

|Dec 23, 2023
Correction: Krayem et al. The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma. Cancers 2019, 11, 1093.

Mohammad Krayem, Malak Sabbah, Ahmad Najem

|Dec 23, 2022
Co-Targeting the EGFR and PI3K/Akt Pathway to Overcome Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma: What about Autophagy?

Hannah Zaryouh, Jinthe Van Loenhout, Marc Peeters

|Apr 30, 2021
Recent insights in the PI3K/Akt pathway as a promising therapeutic target in combination with EGFR-targeting agents to treat head and neck squamous cell carcinoma.

Hannah Zaryouh, Ines De Pauw, Hasan Baysal

|Mar 06, 2021
Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer.

Andreas Domen, Delphine Quatannens, Sara Zanivan

|Mar 06, 2021
Targeting the PD-1 Axis with Pembrolizumab for Recurrent or Metastatic Cancer of the Uterine Cervix: A Brief Update.

Yannick Verhoeven, Delphine Quatannens, Xuan Bich Trinh

Pageof 2

Frequent Collaborators

8 joint publications

Filip Lardon

3 joint publications

Ines De Pauw

3 joint publications

Evelien Smits

2 joint publications

Jolien Van den Bossche